Madrid (Spain), 07.01.04. --Algry Quimica (www.cholines.com), the Spanish manufacturer of pharma and food grade choline salts confirmed that 2003 net sales increased by around 15 per cent over 2002 figures, in their core business of unencapsulated food / pharma grade choline salts, including Choline Chloride, Choline Bitartrate and Choline Citrate.
The company said that first half results, showing sales increases of 14 per cent over the same period in 2002, established a trend in their choline salts segment market, especially in European and the US markets, and most significantly in nutritional and infant food applications.
"Our philosophy of remaining focused on product quality, recent USP standards adoption and ISO 9001:2000 certification for choline salts manufacturing, were the keys to keep our market position, allowing us to increase again choline salts sales and exports in a highly competitive environment during 2003", said Guillermo Rodriguez, Sales Manager at Algry Quimica. "We expect the growth trend to remain stable during 2004, as per new agreements reached with several major companies worldwide to promote, market and distribute our cholines portfolio, which has for many years been our core business"
The company also announced that planned new investments at their choline salts manufacturing facility in Huelva (Spain), have been succesfully completed in order to enlarge production capabilities to meet increasing demand for the unencapsulated cholines market in 2004, both for new and already existing applications. The company also noted that several new products and projects are in the pipeline for 2004 and 2005 launch.